Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 51.33 38.39 53.85 50.00 75.34 73.40 52.65 42.96 52.60 47.42
P/S ratio 12.64 8.75 12.43 10.08 17.45 15.76 9.34 7.30 7.03 5.94
P/FCF ratio 56.88 47.28 59.64 88.38 88.83 78.94 75.78 58.79 46.70 38.49
P/Operating CF 152.94 130.12 182.09 195.77 267.19 194.85 144.69 119.12 114.35 104.73
P/B ratio 33.89 21.37 30.65 55.77 81.31 67.42 126.46 0.00 0.00 0.00
Price to Tangible BV 50.31 31.61 44.00 227.45 242.22 126.62 0.00 0.00 0.00 0.00
EV/Sales 12.71 8.83 12.49 10.28 17.67 15.95 9.72 7.52 7.10 6.06
EV/EBITDA 36.33 27.36 37.74 34.24 54.80 54.63 36.51 28.96 28.19 25.05
EV/Operating CF 46.27 37.06 50.46 63.74 75.19 66.64 50.96 41.58 37.47 31.73
EV/FCF 57.16 47.74 59.95 90.09 89.94 79.91 78.85 60.54 47.16 39.23
Quick Ratio 0.64 0.71 0.96 0.42 0.67 1.23 0.50 0.48 0.70 0.64
Current Ratio 1.23 1.31 1.57 0.89 1.25 1.82 0.94 0.85 0.97 0.90
Net Debt/EBITDA 0.18 0.26 0.20 0.65 0.68 0.66 1.42 1.53 1.59 1.89
Debt/Assets 13.42% 18.75% 21.41% 28.01% 34.88% 39.59% 54.73% 65.07% 73.60% 78.66%
Debt/Equity 0.28 0.39 0.47 1.26 1.23 1.44 5.64 (108.34) (23.42) (11.13)
Asset Turnover 1.30 1.19 1.22 1.30 1.36 1.31 1.43 1.36 1.21 1.18
Operating CF/Net income 1.12 1.05 1.07 0.80 1.01 1.11 1.07 1.06 1.42 1.53
Capex/Depreciation (0.95) (1.01) (1.16) (1.42) (1.14) (1.12) (1.76) (1.48) (0.92) (0.82)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 66.20% 57.66% 80.74% 104.58% 112.62% 143.54% 507.40% (1,195.50%) (324.76%) (231.05%)
ROA 31.89% 27.10% 28.14% 26.20% 31.48% 28.19% 25.39% 23.20% 16.22% 14.77%
ROIC 45.33% 36.64% 39.67% 44.39% 41.74% 37.51% 31.69% 35.41% 35.11% 31.09%
Return on Tangible Assets 104.65% 84.95% 67.83% 131.82% 95.52% 56.20% 87.62% 117.46% 75.94% 82.72%
Average Days of Receivables 46.85 44.35 45.61 43.43 41.81 44.69 40.84 41.04 43.49 42.04
Research and Development Expense of Revenue 5.84% 5.64% 5.22% 7.57% 5.01% 5.22% 5.53% 5.33% 5.54% 5.70%
Selling, General and Administrative Expense of Revenue 24.36% 26.45% 24.64% 25.26% 24.77% 27.17% 28.23% 28.57% 29.21% 29.52%
Intangible Assets out of Total Assets 0.16 0.16 0.14 0.17 0.19 0.13 0.16 0.17 0.14 0.15
Share Based Compensation of Revenue 1.39% 1.55% 1.63% 1.48% 1.17% 1.14% 1.63% 1.14% 1.19% 1.12%
Graham Net Nets (0.01) (0.01) (0.01) (0.03) (0.01) (0.01) (0.04) (0.06) (0.06) (0.08)
Graham Number 76.94 68.47 63.95 36.47 39.91 33.71 15.18 0.00 0.00 0.00
Earnings Yield 1.95% 2.60% 1.86% 2.00% 1.33% 1.36% 1.90% 2.33% 1.90% 2.11%
Free Cash Flow Yield 1.76% 2.11% 1.68% 1.13% 1.13% 1.27% 1.32% 1.70% 2.14% 2.60%
Revenue per Share 53.51 47.26 44.07 40.27 37.74 31.72 27.95 25.48 22.43 19.79
Operating CF per Share 14.69 11.27 10.91 6.49 8.87 7.59 5.33 4.61 4.25 3.78
Capex per Share (1.72) (1.59) (1.61) (1.90) (1.40) (1.26) (1.80) (1.42) (0.87) (0.72)
Free Cash Flow per Share 12.98 9.68 9.30 4.59 7.46 6.33 3.53 3.19 3.38 3.06
Cash per Share 2.24 3.50 5.46 1.35 1.70 4.50 1.05 1.43 5.38 4.37
Shareholders Equity per Share 19.96 19.34 17.87 7.28 8.10 7.41 2.07 (0.11) (0.61) (1.21)
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 19.96 19.34 17.87 7.28 8.10 7.41 2.07 (0.11) (0.61) (1.21)
Free Cash Flow 1,043.58 798.08 772.88 384.15 636.00 540.44 303.93 277.15 296.57 274.16
Working Capital 265.01 331.98 543.71 (134.33) 192.08 479.98 (45.70) (116.27) (32.58) (88.98)
Capital Expenditures (138.23) (130.92) (133.63) (158.84) (119.55) (107.63) (155.22) (122.94) (76.70) (64.79)
Net Current Asset Value (331.55) (298.23) (280.14) (1,036.55) (791.56) (599.03) (975.01) (892.41) (795.27) (793.33)
EV/EBIT 40.21 30.51 41.69 38.51 60.95 62.18 42.33 33.86 33.86 30.71
Capex to Sales 0.03 0.03 0.04 0.05 0.04 0.04 0.06 0.06 0.04 0.04
Net Profit Margin 24.62% 22.78% 23.08% 20.17% 23.17% 21.49% 17.77% 17.04% 13.36% 12.51%
Price to Operating Income 40.01 30.22 41.47 37.78 60.19 61.42 40.68 32.89 33.53 30.13
Other line items
Depreciation/Fixed assets 0.19 0.18 0.16 0.17 0.18 0.17 0.16 0.19 0.22 0.22
Cash ROIC 19.43% 8.63% 7.75% (7.14%) 9.97% 4.83% (5.88%) (3.34%) (0.35%) (1.24%)
Accounts Receivable Turnover 8.39 8.37 8.53 8.76 9.19 9.01 9.29 9.16 8.97 9.04
Accounts Payable Turnover 14.64 13.51 13.32 12.04 13.91 15.48 14.70 14.24 13.72 14.20
Inventory Turnover 4.33 3.98 3.93 4.28 5.54 5.61 5.65 5.76 5.41 4.61
Average Days of Payables 24.51 27.45 27.45 29.52 31.97 23.96 25.30 26.12 28.04 27.40
Days of Inventory on Hand 83.86 91.79 94.36 98.50 74.06 67.46 68.35 65.10 68.81 72.10
Average Receivables 512.98 465.51 429.03 384.48 349.89 300.37 259.08 241.73 219.55 196.41
Average Payables 112.31 112.43 110.43 113.18 95.35 73.37 70.85 68.25 63.51 56.35
Average Inventory 379.82 381.08 374.05 318.43 239.45 202.45 184.16 168.81 161.18 173.43
Average Assets 3,322.10 3,276.68 3,003.35 2,591.98 2,365.88 2,063.52 1,684.91 1,625.38 1,622.06 1,502.85
Average Common Equity 1,600.35 1,539.92 1,046.63 649.36 661.39 405.31 84.30 (31.54) (81.03) (96.10)

Fold the line items

Columns are period end dates